✦ LIBER ✦

Proceedings of the international conference on androgenic hormones, prostate cancer, and benign prostatic hyperplasia

✍ Scribed by Hussain, Maha; Montie, James

Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 112 KB
Volume: 29
Category: Article
ISSN: 0270-4137
DOI: 10.1002/(sici)1097-0045(1996)6+<1::aid-pros1>3.0.co;2-v

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Measurement of complexed PSA in the diff

Measurement of complexed PSA in the differential diagnosis between prostate cancer and benign prostate hyperplasia

✍ Filella, Xavier; Alcover, Juan; Molina, Rafael; Corral, Juan Manuel; Carretero, 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 2 views

## Background: To enhance the specificity of psa in diagnosis of cancer, several approaches have been evaluated, having in common the study of fractions of psa. the aim of this study was to evaluate the usefulness of complexed psa in the differential diagnosis between benign prostate hyperplasia (b

The influence of prostate volume on the

The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia

✍ Carsten Stephan; Michael Lein; Klaus Jung; Dietmar Schnorr; Stefan A. Loening 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views

T1, 2, 3pN0, M0), 44 patients with BPH, and 54 healthy Charite ´, Humboldt University Berlin, Berlin, Gercontrols. Prostate volume was determined by transrectal ultrasound. many. ## RESULTS. The median values of t-PSA and f-PSA% were 7.8 mg/L and 10.5% in PCa patients, 4.3 mg/L and 20.8% in patie

On the prediction of the histologic comp

On the prediction of the histologic composition of benign prostatic hyperplasia based on clinical and MRI parameters

✍ Weijers, René E.; Zambon, Jan-Victor; Kessels, Alfons G.H.; de Bruïne, Adriaan P 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 456 KB 👁 1 views

## Background: The histologic composition of prostate adenoma seems related to the development of clinical benign prostatic hyperplasia (bph). therefore, a new noninvasive prediction model as an alternative for biopsies was investigated. ## Methods: In 19 patients, the data of a routine preoperat

CAG repeat within the androgen receptor

CAG repeat within the androgen receptor gene and incidence of surgery for benign prostatic hyperplasia in U.S. physicians

✍ Giovannucci, Edward; Stampfer, Meir J.; Chan, Andrew; Krithivas, Krishna; Gann, 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 1 views

BACKGROUND. CAG repeat length in exon 1 of the androgen receptor (AR) gene correlates inversely with transcriptional transactivation activity of the AR. Men with shorter AR CAG repeat lengths are at higher risk of prostate cancer. Because benign prostatic hyperplasia (BPH) is an androgen-dependent c

The androgen receptor gene and its influ

The androgen receptor gene and its influence on the development and progression of prostate cancer

✍ Jeffrey S. Montgomery; Douglas K. Price; William D. Figg 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 1 views

Effects of long-term treatment withSeren

Effects of long-term treatment withSerenoa repens (Permixon®) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia

✍ Di Silverio, F.; Monti, S.; Sciarra, A.; Varasano, P.A.; Martini, C.; Lanzara, S 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB 👁 1 views

## Background: The n-hexane lipido-sterol extract of serenoa repens (lsesr, permixon, pierre fabre medicament, castres, france), a phytotherapeutic agent used in the treatment of benign prostatic hyperplasia (bph), has a multisite mechanism of action including inhibition of types 1 and 2 5alpha-red